The method is provided for characterizing agglomeration of particles in a liquid containing an analyte, including introducing liquid into a fluid chamber; mixing the liquid with a bifunctional reagent, lighting the fluid chamber using an excitation light beam extending through the fluid chamber in a longitudinal direction (X); acquiring at least one image using a matrix photodetector, each image including pixels (I.sub.n(x,y), x,y representing the coordinates of a pixel of an image, the image (I(x,y)) being formed by radiation transmitted by the lighted fluid chamber; and calculating from at least one acquired image (I(x,y)), at least one indicator (Ind2) characterizing the particle agglomeration. The photodetector can be positioned less than 1 cm from the fluid chamber, and during the calculation step, the calculated indicator (Ind2) is representative of the intensity of the pixels of the image. The method advantageously allows for characterizing the agglomeration of particles in a liquid.

A method for detecting at least one analyte in at least one sample of a body fluid is disclosed. Therein, at least one test element (124) is used, the at least one test element (124) having at least one test field (162) with at least one test chemistry (154) is used, wherein the test chemistry (154) is adapted to perform at least one optically detectable detection reaction in the presence of the analyte. The method comprises acquiring an image sequence of images of the test field (162) by using at least one image detector (178). Each image comprises a plurality of pixels. The method further comprises detecting at least one characteristic feature of the test field (162) in the images of the image sequence. The method further comprises correcting a relative position change between the image detector (178) and the test field (162) in the image sequence by using the characteristic feature, thereby obtaining a sequence of corrected images.

A method of measuring phenotypic expression of T2Rs and/or TIRs for a subject to predict taste preferences for wines may include stimulating T2Rs and/or TIRs of a subject with agonists and detecting products released as a result of stimulation of the T2Rs and/or T1Rs. A method may include recording discerned levels of taste perception after stimulation with agonists and correlating the discerned level to phenotypic expression, which may be used to predict taste preferences for wine profiles. A method may include calculating wine bin scores for predicted wine preferences, from phenotypic expression of T2Rs and/or T1Rs, obtaining taste preference information, and determining the subject's taste preference scores for wines administered to the subject.

Multi-stage sample-recovery systems, including automated 2-stage and 3-stage sample-recovery systems, are provided. Such systems enable the rapid screening and recovery of samples, including viable cell-based samples, from high-throughput screening systems, including systems utilizing large-scale arrays of microcapillaries. In specific screening systems, each microcapillary comprises a solution containing a variant protein, an immobilized target molecule, and a reporter element. Immobilized target molecules may include any molecule of interest, including proteins, nucleic acids, carbohydrates, and other biomolecules. The association of a variant protein with a molecular target is assessed by measuring a signal from the reporter element. The contents of microcapillaries identified in the assays as containing variant proteins of interest can be identified and recovered using the multi-stage systems disclosed herein.

A liquid crystal composition includes a nematic liquid crystal, and a compound of Formula (I) where R is an alkyl, aryl, aralkyl or heteroaryl having 6 to 30 carbon atoms, wherein the compound accounts for 0.3 to 0.6% of the liquid crystal composition.

##STR00001##

Further, a sensing device includes a substrate, a frame, an alignment film, the liquid crystal composition as described above, and two polarizers. The frame is connected to the substrate and forms an accommodation space having an opening, and the alignment film and the liquid crystal composition are both located inside the accommodation space. One of the polarizers is arranged in correspondence with the opening such that a channel exists between the polarizer and the frame, the other polarizer is located at a lateral side of the substrate, and the polarization directions of the two polarizers intersect with each other.

A method for detecting at least one analyte in at least one sample of a body fluid is disclosed. Therein, at least one test element (124) is used, the at least one test element (124) having at least one test field (162) with at least one test chemistry (154) is used, wherein the test chemistry (154) is adapted to perform at least one optically detectable detection reaction in the presence of the analyte. The method comprises acquiring an image sequence of images of the test field (162) by using at least one image detector (178). Each image comprises a plurality of pixels. The method further comprises detecting at least one characteristic feature of the test field (162) in the images of the image sequence. The method further comprises correcting a relative position change between the image detector (178) and the test field (162) in the image sequence by using the characteristic feature, thereby obtaining a sequence of corrected images.

A wrapper for a terahertz wave according to an embodiment of the present invention includes: a terahertz wave transmission layer that is made of a material that transmits a terahertz wave; and an electric field enhancement structure that enhances an electric field by reacting with a predetermined frequency band of terahertz waves passing through the terahertz wave transmission layer. An optical identification device for a terahertz wave according to an embodiment of the present invention includes m identification units composed of: a terahertz wave transmission layer that is made of a material that transmits a terahertz wave; and a waveguide grating that resonates at a natural resonant frequency when receiving the transmitted terahertz wave, in which the natural resonant frequency is any one of a first natural resonant frequency to an n-th natural resonant frequency.

A photonic crystal laser and a strain measuring device are provided. The photonic crystal laser includes a disk-shaped photonic crystal structure two-dimensionally disposed in a matrix on a disposition plane and a flexible substrate disposed to support the photonic crystal structure and to cover at least a side surface of the photonic crystal structure.

A test system may be used to measure biological samples and other samples. Samples may be placed on a test substrate such as a test slide or other transparent substrate. The substrate may have patches of reactant-coated gold nanorods or other nanostructures that exhibit plasmonic resonances. An accessory may be removably coupled to a portable electronic device such as a cellular telephone. The accessory may have a lens and a light source that emits light into an edge of the test slide. The light may scatter from the nanostructures in a perpendicular direction towards a camera in the portable electronic device so that the portable electronic device can gather images of the illuminated substrate and measure spectral shifts associated with reactions between the samples and the reactant, thereby helping to analyze the composition of the samples.

The present invention is to present a status notification method for the sample analyzer. The method includes a detection step for detecting the status of the sample analyzer for analyzing the sample, and an irradiating step for irradiating light upward in accordance with the detection step.